Uniphar has announced a strategic merger between its clinical trial services division, Uniphar | Clinical, and BMclinical, creating a unified global partner for clinical trial supply. The merger strengthens Uniphar | Clinical’s integrated supply platform and brings BMclinical’s deep expertise in comparator sourcing into a single comprehensive offering.

This combined service is designed to support every stage of clinical trial logistics, including sourcing, packaging, labeling, storage and distribution of clinical materials, while improving continuity and reducing risk from study initiation to completion. The expanded capabilities aim to streamline global supply chains and help sponsors bring therapies to patients more efficiently as trials grow in complexity. With strategically located facilities in the Netherlands and the United States and a distribution footprint across Europe, North America, APAC and the Middle East, the merged organisation enhances reliability and agility for pharmaceutical and biotech partners. Leaders from both organisations say the merger creates a broader, more dependable suite of services that anticipates challenges and supports sponsors throughout trial execution.